Table 3 Clinical audit data presenting number of women receive any examination or procedures according to the pathways
Items (in a month pilot implementation) | Number of pregnant women (n) | ||||
|---|---|---|---|---|---|
Puskesmas 1 | Puskesmas 2 | Puskesmas 3 | Total | Mean | |
Visiting women | 112 | 267 | 197 | 576 | 192 |
Women screened with preeclampsia risk factors | 92 | 15 | 34 | 141 | 47 |
Women with one high-risk or at least two moderate risk-factors for preeclampsia | 5 | 20 | 10 | 35 | 11.7 |
Women tested with dipstick protein urine | 13 | 51 | 14 | 78 | 26 |
Women went for liver and kidney function tests | 0 | 0 | 2 | 2 | 0.7 |
Women received aspirin as preeclampsia prophylaxis | 2 | 17 | 5 | 24 | 8 |
Women received antihypertensive medication | 5 | 0 | 3 | 8 | 2.7 |
Number of women referred to the hospitals from HDP | 2 | 3 | 2 | 7 | 2.3 |